Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Optimal outcomes from depression treatment are long-term recovery and, in the case of recurrent depression, prevention of new episodes. However, few data are available concerning the long-term efficacy of antidepressants in prophylactic treatment to prevent recurrences of depression. The efficacy and safety of fluoxetine 20 mg/day was evaluated in reducing the number of depressive episodes and in extending the time free of symptoms in patients with recurrent unipolar major depression. Patients with recurrent unipolar major depression according to DSM-III-R criteria and who responded to 32 weeks of open-label fluoxetine were randomly assigned to receive fluoxetine 20 mg/day (N = 70) or placebo (N = 70) for 48 weeks of double-blind maintenance treatment. Outcome measures were the percentage of recurrences and time to recurrence. Safety assessments included treatment-emergent adverse events, reasons for discontinuation, vital signs, and laboratory measures. Fluoxetine was associated with a statistically significantly smaller percentage of patients who had a recurrence compared with placebo (20% vs. 40%; chi2 analysis, p = 0.010). The symptom-free period was significantly longer for patients treated with fluoxetine versus placebo (295 vs. 192 days; Kaplan-Meier estimates, log-rank test, p = 0.002). Treatments were well tolerated during maintenance treatment. The only statistically significant difference in adverse events between treatment groups was anxiety, which was more frequent in the placebo group (fluoxetine, 12.9% vs. placebo, 30%; chi2 analysis, p = 0.013). Two placebo-treated patients and no fluoxetine-treated patients were withdrawn because of adverse events. In conclusion, fluoxetine at 20 mg/day was effective and well tolerated for the prophylactic treatment of recurrent unipolar major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.795 · Cited by 228
Terra, J. L., & Montgomery, S. A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00001 · Cited by 51
Research works printed but not linked: 12
- Murray, 1997, Lancet, 349, 1436, 10.1016/S0140-6736(96)07495-8 · DOI · Paper page
- Thase, 1995, CNS Drugs, 4, 261, 10.2165/00023210-199504040-00004 · DOI
- Prien, 1986, Am J Psychiatry, 143, 18, 10.1176/ajp.143.1.18 · DOI · Paper page
- Demyttenaere, 1998, Int Clin Psychopharmacol, 13, 11, 10.1097/00004850-199801000-00002 · DOI · Paper page
- Montgomery, 1989, Neuropsychobiology, 22, 214, 10.1159/000118619 · doi:10.1159/000118619
- Keller, 1998, JAMA, 280, 1665, 10.1001/jama.280.19.1665 · DOI · Paper page
- 1985, Am J Psychiatry, 142, 469, 10.1176/ajp.142.4.469 · DOI · Paper page
- Frank, 1990, Arch Gen Psychiatry, 47, 1093, 10.1001/archpsyc.1990.01810240013002 · DOI · Paper page
- Montgomery, 1993, Int Clin Psychopharmacol, 8, 189, 10.1097/00004850-199300830-00009 · DOI · Paper page
- Doogan, 1992, Br J Psychiatry, 160, 217, 10.1192/bjp.160.2.217 · DOI · Paper page
- Franchini, 1997, J Clin Psychiatry, 58, 104, 10.4088/JCP.v58n0303 · DOI · Paper page
- Reimherr, 1998, Am J Psychiatry, 155, 1247, 10.1176/ajp.155.9.1247 · DOI · Paper page
Cited by
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression
Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Depression (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01377.x · Cited by 257
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Hansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1121 · Cited by 172
Metadata
- Authors
- Gilaberte, I., Montejo, A. L., de la Gandara, J., Perez-Sola, V., Bernardo, M., Massana, J., Martin-Santos, R., Santiso, A., Noguera, R., Casais, L., Perez-Camo, V., Arias, M., & Judge, R.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2001-08
- Volume
- 21
- Issue
- 4
- Pages
- 417-424
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2063767287
- Cited by
- 58
- References
- 2
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study. https://app.cochat.ai/papers/10.1097/00004714-200108000-00009
- The paper
- Gilaberte, I., Montejo, A. L., de la Gandara, J., Perez-Sola, V., Bernardo, M., Massana, J., Martin-Santos, R., Santiso, A., Noguera, R., Casais, L., Perez-Camo, V., Arias, M., & Judge, R. (2001). Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200108000-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.